Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01965548
Other study ID # Miltstudie1
Secondary ID
Status Completed
Phase N/A
First received October 15, 2013
Last updated January 8, 2016
Start date September 2014
Est. completion date October 2015

Study information

Verified date December 2015
Source University Hospital of North Norway
Contact n/a
Is FDA regulated No
Health authority Norway: Data Protection Authority
Study type Observational

Clinical Trial Summary

In blunt trauma, the spleen is most frequent injured organ in the abdomen and the most frequent source of bleeding in the abdomen.

Historically, splenectomy was the treatment of choice for splenic bleeding. For exsanguinating patients, open splenectomy is still the proper choice of treatment if the spleen is a significant source of bleeding. However, for hemodynamic stable patients with splenic injury, non-operative management (NOM) is an alternative, assuming they have no other indication for surgery (peritonitis).

Non-operative management includes observation and/or splenic artery embolisation (SAE), but the indications for observation and SAE varies between trauma centers. The greatest advantage of NOM is the preservation of splenic function.

In the investigators hospital splenic artery embolisation was introduced in 2007. The investigators want to describe the treatment of splenic injuries in their hospital, to see if the number of splenectomies has been recduced after 2007, and to see if SAE has also been used in transferred trauma patients.


Recruitment information / eligibility

Status Completed
Enrollment 109
Est. completion date October 2015
Est. primary completion date October 2015
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- All patients admitted at UNN Tromsø in the period of 01.01.2000 - 31.12.2013 and with the discharge diagnosis S36.0 Splenic injury (ICD-10)

Exclusion Criteria:

- no injury/coding error

- iatrogenic injury

- transfer >7 days after injury

- >10 days between injury and first hospital admission

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Procedure:
Treatment of splenic injury
There are four possible treatments of splenic injury in this study: splenectomy splenic artery embolisation non-operative management any combination of the three treatments mentioned

Locations

Country Name City State
Norway University Hospital North Norway Tromsø Tromsø

Sponsors (1)

Lead Sponsor Collaborator
University Hospital of North Norway

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary type of splenic trauma treatment There are three different treatments of splenic trauma treatment, resulting in four different treatments:
splenectomy
splenic artery embolization
non-operative management
any combination of the three treatments
0-7 days No
Secondary Mortality 30 days No
Secondary Length of hospital stay 1 - 90 days No
Secondary Length of stay in the intensive care unit 0 - 90 days No
Secondary Emergency procedures Emergency procedures includes:
Chest tube insertion
Hemostatic surgery in the abdomen
Hemostatic surgery in the pelvis with packing
Thoracotomy
Primary stabilization of fractures (external fixation)
Endotracheal intubation
0 - 7 days No